Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Volitionrx (VNRX) Shares Issued (2019 - 2025)

Historic Shares Issued for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$28597.0.

  • Volitionrx's Shares Issued fell 10047.98% to -$28597.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 1481.63%. This contributed to the annual value of $8.6 million for FY2024, which is 6973.31% down from last year.
  • Per Volitionrx's latest filing, its Shares Issued stood at -$28597.0 for Q3 2025, which was down 10047.98% from $3.4 million recorded in Q2 2025.
  • Volitionrx's 5-year Shares Issued high stood at $19.4 million for Q2 2021, and its period low was -$85567.0 during Q3 2023.
  • Its 5-year average for Shares Issued is $3.8 million, with a median of $1.8 million in 2021.
  • Data for Volitionrx's Shares Issued shows a peak YoY increase of 58178563333.33% (in 2023) and a maximum YoY decrease of 10143.93% (in 2023) over the last 5 years.
  • Over the past 5 years, Volitionrx's Shares Issued (Quarter) stood at $1.8 million in 2021, then crashed by 56.15% to $781794.0 in 2022, then skyrocketed by 231.59% to $2.6 million in 2023, then dropped by 21.82% to $2.0 million in 2024, then plummeted by 101.41% to -$28597.0 in 2025.
  • Its last three reported values are -$28597.0 in Q3 2025, $3.4 million for Q2 2025, and $2.4 million during Q1 2025.